Literature DB >> 18291265

Bile and pancreatic juice exclusion activates acinar stress kinases and exacerbates gallstone pancreatitis.

Isaac Samuel1.   

Abstract

HYPOTHESIS: Bile and pancreatic juice exclusion from gut activates acinar stress kinases and exacerbates gallstone pancreatitis as evidenced by the ameliorating effects of replacement therapy in an experimental model of duct ligation-induced acute pancreatitis. In the early stages of gallstone pancreatitis, bile-pancreatic juice cannot enter the gut. Enteral exclusion worsens pancreatitis by causing feedback hyperstimulation of the exocrine pancreas that activates acinar cell stress kinases. Investigations using a unique surgical model, the Donor Rat Model, showed that duodenal replacement of bile-pancreatic juice in rats with duct ligation attenuates pancreatic stress kinase activation, reduces pancreatic cytokine production, and ameliorates pancreatic morphologic changes. These findings suggest that exclusion-induced acinar hyperstimulation, in the presence of duct obstruction, exacerbates acute pancreatitis via stress kinase activation. Although acinar hyperstimulation has often been implicated in the pathogenesis of acute pancreatitis, the lack of supporting evidence remains a conspicuous void. The proposed hypothesis draws on fresh evidence to present a new paradigm that reexamines the role of exocrine pancreatic hyperstimulation in gallstone pancreatitis pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18291265      PMCID: PMC2278165          DOI: 10.1016/j.surg.2007.06.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  12 in total

1.  Interactions between bile and pancreatic juice diversions on cholecystokinin release and pancreas in conscious rats.

Authors:  R Nakamura; K Miyasaka; A Funakoshi; K Kitani
Journal:  Proc Soc Exp Biol Med       Date:  1989-11

2.  In vitro evidence for role of ERK, p38, and JNK in exocrine pancreatic cytokine production.

Authors:  Isaac Samuel; Asgar Zaheer; Rory A Fisher
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

3.  Involvement of cholecystokinin receptors in the adverse effect of glucocorticoids on diet-induced necrotizing pancreatitis.

Authors:  G Gomez; C M Townsend; D Green; S Rajaraman; T Uchida; J C Thompson
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

Review 4.  Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors.

Authors:  K Miyasaka; A Funakoshi
Journal:  Pancreas       Date:  1998-04       Impact factor: 3.327

5.  Mechanism of acute pancreatitis exacerbation by enteral bile-pancreatic juice exclusion.

Authors:  Isaac Samuel; Yasuo Toriumi; Asgar Zaheer; Raymond J Joehl
Journal:  Pancreatology       Date:  2004-08-27       Impact factor: 3.996

6.  Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction.

Authors:  Y Toriumi; I Samuel; D P Wilcockson; C M Turkelson; T E Solomon; R J Joehl
Journal:  J Surg Res       Date:  1993-02       Impact factor: 2.192

7.  Bile-pancreatic juice replacement not cholinergic- and cholecystokinin-receptor blockade reverses acinar cell hyperstimulation after bile-pancreatic duct ligation.

Authors:  I Samuel; R J Joehl
Journal:  Am J Surg       Date:  1996-01       Impact factor: 2.565

8.  Evaluation of atropine in acute pancreatitis.

Authors:  J L Cameron; D Mehigan; G D Zuidema
Journal:  Surg Gynecol Obstet       Date:  1979-02

Review 9.  New insights into neurohormonal regulation of pancreatic secretion.

Authors:  Chung Owyang; Craig D Logsdon
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  Bile and pancreatic juice replacement ameliorates early ligation-induced acute pancreatitis in rats.

Authors:  I Samuel; Y Toriumi; D P Wilcockson; C M Turkelson; T E Solomon; R J Joehl
Journal:  Am J Surg       Date:  1995-04       Impact factor: 2.565

View more
  8 in total

1.  Dominant negative p38 mitogen-activated protein kinase expression inhibits NF-kappaB activation in AR42J cells.

Authors:  Erik Twait; Deborah E Williard; Isaac Samuel
Journal:  Pancreatology       Date:  2010-05-07       Impact factor: 3.996

2.  Systemic inflammation with multiorgan dysfunction is the cause of death in murine ligation-induced acute pancreatitis.

Authors:  Zuobiao Yuan; David K Meyerholz; Erik C Twait; Duraisamy Kempuraj; Deborah E Williard; Isaac Samuel
Journal:  J Gastrointest Surg       Date:  2011-07-29       Impact factor: 3.452

Review 3.  Etiology and diagnosis of acute biliary pancreatitis.

Authors:  Erwin J M van Geenen; Donald L van der Peet; Pranav Bhagirath; Chris J J Mulder; Marco J Bruno
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

4.  Enteral exclusion increases MAP kinase activation and cytokine production in a model of gallstone pancreatitis.

Authors:  Isaac Samuel; Linda Tephly; Deborah E Williard; A Brent Carter
Journal:  Pancreatology       Date:  2008-01-31       Impact factor: 3.996

Review 5.  Acute pancreatitis: etiology and common pathogenesis.

Authors:  Guo-Jun Wang; Chun-Fang Gao; Dong Wei; Cun Wang; Si-Qin Ding
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742

6.  Biliary pancreatitis. Deadly threat to the elderly. Is it a real threat?

Authors:  Arshad Mehmood Malik
Journal:  Int J Health Sci (Qassim)       Date:  2015-01

7.  Experimental obstructive cholestasis: the wound-like inflammatory liver response.

Authors:  María-Angeles Aller; Jorge-Luis Arias; Jose García-Domínguez; Jose-Ignacio Arias; Manuel Durán; Jaime Arias
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03

8.  Severe acute gallstone pancreatitis with diffuse hemorrhagic gastritis.

Authors:  Timothy J Harris; William C Beck; Avi Bhavaraju; Benjamin Davis; Mary K Kimbrough; Joseph C Jensen; Anna Privratsky; John R Taylor; Kevin W Sexton
Journal:  J Surg Case Rep       Date:  2018-03-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.